Yajie Zhu Jianning Tang Xin Li Tian Qin Yang Wei
10.2147/OTT.S268593
Onco Targets Ther
2020 Oct 14;13:10447-10451.
d761y egfr nsclc compound mutation icotinib osimertinib
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/33116624/
Case Reports
PMC7569175
33116624
Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation
2020